News
United Therapeutics Corporation (UTHR) Completes Phase 3 Enrollment for Promising PAH Drug Ralinepag
United Therapeutics Corporation (NASDAQ:UTHR) is among the most undervalued stocks to invest in. It is a biotechnology ...
In June 2025, the FDA approved KEYTRUDA for perioperative use in adults with resectable, locally advanced head and neck ...
In February 2025, Biogen Inc. (NASDAQ:BIIB) formed a partnership with Stoke Therapeutics to develop zorevunersen for Dravet ...
With a self-funded model and a focus on high-unmet-need areas in neuroscience, Alkermes plc (NASDAQ:ALKS) continues to ...
AstraZeneca PLC (NASDAQ:AZN), a global biopharmaceutical company headquartered in Cambridge, UK, operates in over 130 ...
Johnson & Johnson (NYSE:JNJ) is a global healthcare leader with a diverse portfolio across pharmaceuticals, medical devices, ...
Although dividend growth continued to slow during the second quarter, there are some positive signs for what may come next.
He stated that the market deserves the benefit of the doubt, as what got us here is the performance of growth sectors like ...
We came across a bullish thesis on The Boeing Company on Deep Value Capital’s Substack. In this article, we will summarize ...
The US has recently reversed a ban on Nvidia that restricted them from sending its export control-compliant chip known as the ...
US equity markets are back at all-time highs amid a muted response to new U.S. tariffs and the trade war. The Nasdaq ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results